Voyager Therapeutics Inc (VYGR)
EBITDA Growth
27.11%
Quarterly · Period ending:
VYGR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported27.11%period ending
Latest reported27.11%period ending
VYGR Quarterly EBITDA YoY % (-57.51% → 27.11%)
Year-over-year change
High-resolution chart · PNG
VYGR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 27.1098% | |
| 9.9399% | |
| 19.8346% | |
| -241.5555% | |
| -270.2235% | |
| -196.1462% | |
| -156.1757% | |
| 68.2433% | |
| 58.5767% | |
| -108.043% | |
| 357.0776% | |
| -230.6565% | |
| -17.7823% | |
| 779.8671% | |
| -390.7327% | |
| 179.3083% | |
| 38.196% | |
| 23.8865% | |
| 134.4473% | |
| -127.9393% | |
| -259.2179% | |
| -3.069% | |
| -74.804% | |
| 600.7547% | |
| -168.0954% | |
| 17.7355% | |
| 40.737% | |
| 16.9525% | |
| 147.2687% | |
| -38.9592% | |
| -84.2931% | |
| 10.2129% | |
| -37.2737% | |
| -19.9477% | |
| 12.9112% | |
| -124.4834% | |
| -92.584% | |
| -134.6883% | |
| -87.9879% | |
| -164.6022% | |
| -147.6714% | |
| -56.0783% | |
| -65.9293% | |
| -7.4033% | |
| -18.5852% | |
| -57.5117% |